These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
86 related articles for article (PubMed ID: 18049186)
1. Papanicolaou smears induce partial immunity against sexually transmitted viral infections. Shapiro S; Hoffman M; Constant D; Rosenberg L; Carrara H; Allan BR; Marais DJ; Passmore JA; Williamson AL Epidemiology; 2007 Nov; 18(6):709-15. PubMed ID: 18049186 [TBL] [Abstract][Full Text] [Related]
2. Type-specific HPV infection and multiple HPV types: prevalence and risk factor profile in nearly 12,000 younger and older Danish women. Nielsen A; Kjaer SK; Munk C; Iftner T Sex Transm Dis; 2008 Mar; 35(3):276-82. PubMed ID: 18091564 [TBL] [Abstract][Full Text] [Related]
3. Prevalence of genital human papilloma virus infection and genotypes among young women in Sicily, South Italy. Ammatuna P; Giovannelli L; Matranga D; Ciriminna S; Perino A Cancer Epidemiol Biomarkers Prev; 2008 Aug; 17(8):2002-6. PubMed ID: 18708390 [TBL] [Abstract][Full Text] [Related]
4. Hypothesis: the act of taking a Papanicolaou smear reduces the prevalence of human papillomavirus infection: a potential impact on the risk of cervical cancer. Shapiro S; Carrara H; Allan BR; Hoffman M; Rosenberg L; Kelly JP; Cooper DD; Williamson AL Cancer Causes Control; 2003 Dec; 14(10):953-7. PubMed ID: 14750534 [TBL] [Abstract][Full Text] [Related]
5. Smoking and human papillomavirus infection: pooled analysis of the International Agency for Research on Cancer HPV Prevalence Surveys. Vaccarella S; Herrero R; Snijders PJ; Dai M; Thomas JO; Hieu NT; Ferreccio C; Matos E; Posso H; de Sanjosé S; Shin HR; Sukvirach S; Lazcano-Ponce E; Muñoz N; Meijer CJ; Franceschi S; Int J Epidemiol; 2008 Jun; 37(3):536-46. PubMed ID: 18316350 [TBL] [Abstract][Full Text] [Related]
6. Informational needs and the experiences of women with abnormal Papanicolaou smears. Bertram CC; Magnussen L J Am Acad Nurse Pract; 2008 Sep; 20(9):455-62. PubMed ID: 18786022 [TBL] [Abstract][Full Text] [Related]
7. Epidemiology and genotype distribution of human papillomavirus (HPV) in women of Sardinia (Italy). Masia G; Mazzoleni AP; Contu G; Laconi S; Minerba L; Montixi S; Montis F; Onano A; Porcedda E; Coppola RC Vaccine; 2009 May; 27 Suppl 1():A11-6. PubMed ID: 19480954 [TBL] [Abstract][Full Text] [Related]
8. HPV and cervical cancer testing and prevention: knowledge, beliefs, and attitudes among Hispanic women. Vanslyke JG; Baum J; Plaza V; Otero M; Wheeler C; Helitzer DL Qual Health Res; 2008 May; 18(5):584-96. PubMed ID: 18337618 [TBL] [Abstract][Full Text] [Related]
9. Human papilloma virus types in the oral and cervical mucosa of HIV-positive South African women prior to antiretroviral therapy. Richter KL; van Rensburg EJ; van Heerden WF; Boy SC J Oral Pathol Med; 2008 Oct; 37(9):555-9. PubMed ID: 18355174 [TBL] [Abstract][Full Text] [Related]
10. Cervical cancer screening in medically underserved California Latina and non-Latina women: effect of age and regularity of Pap testing. Howell LP; Gurusinghe S; Tabnak F; Sciortino S Cancer Detect Prev; 2009; 32(5-6):372-9. PubMed ID: 19264426 [TBL] [Abstract][Full Text] [Related]
11. Age at sexual initiation and number of sexual partners in the female Spanish population Results from the AFRODITA survey. de Sanjose S; Cortés X; Méndez C; Puig-Tintore L; Torné A; Roura E; Bosch FX; Castellsague X Eur J Obstet Gynecol Reprod Biol; 2008 Oct; 140(2):234-40. PubMed ID: 18499332 [TBL] [Abstract][Full Text] [Related]
12. High-grade cervical abnormalities and screening intervals in New South Wales, Australia. Schindeler S; Morrell S; Zuo Y; Baker D J Med Screen; 2008; 15(1):36-43. PubMed ID: 18416954 [TBL] [Abstract][Full Text] [Related]
13. Papanicolaou testing among Vietnamese Americans: results of a multifaceted intervention. Nguyen TT; McPhee SJ; Gildengorin G; Nguyen T; Wong C; Lai KQ; Lam H; Mock J; Luong TN; Bui-Tong N; Ha-Iaconis T Am J Prev Med; 2006 Jul; 31(1):1-9. PubMed ID: 16777536 [TBL] [Abstract][Full Text] [Related]
14. Cervical human papillomavirus incidence and persistence in a cohort of HIV-negative women in Zimbabwe. Fukuchi E; Sawaya GF; Chirenje M; Magure T; Tuveson J; Ma Y; Shiboski S; Da Costa M; Palefsky J; Moscicki AB; Makunike-Mutasa R; Chipato T; Smith-McCune KK Sex Transm Dis; 2009 May; 36(5):305-11. PubMed ID: 19295468 [TBL] [Abstract][Full Text] [Related]
15. Prevalence and risk factors for carcinogenic human papillomavirus infections in rural Rakai, Uganda. Safaeian M; Kiddugavu M; Gravitt PE; Gange SJ; Ssekasanvu J; Murokora D; Sklar M; Serwadda D; Wawer MJ; Shah KV; Gray R Sex Transm Infect; 2008 Aug; 84(4):306-11. PubMed ID: 18385223 [TBL] [Abstract][Full Text] [Related]
16. High-risk HPV DNA detected in less than 2% of over 25,000 cytology negative imaged liquid-based Pap test samples from women 30 and older. Bansal M; Austin RM; Zhao C Gynecol Oncol; 2009 Nov; 115(2):257-61. PubMed ID: 19665217 [TBL] [Abstract][Full Text] [Related]
17. A case-control study of the protective benefit of cervical screening against invasive cervical cancer in NSW women. Yang B; Morrell S; Zuo Y; Roder D; Tracey E; Jelfs P Cancer Causes Control; 2008 Aug; 19(6):569-76. PubMed ID: 18286380 [TBL] [Abstract][Full Text] [Related]
18. The integration of STD/HIV services with contraceptive services for young women in the United States. Farr SL; Kraft JM; Warner L; Anderson JE; Jamieson DJ Am J Obstet Gynecol; 2009 Aug; 201(2):142.e1-8. PubMed ID: 19481723 [TBL] [Abstract][Full Text] [Related]
19. [Updated cervical cancer screening; human papilloma virus and Papanicolaou tests]. Sasagawa T Rinsho Byori; 2009 Sep; 57(9):905-12. PubMed ID: 19860220 [TBL] [Abstract][Full Text] [Related]
20. Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers. Gillison ML; D'Souza G; Westra W; Sugar E; Xiao W; Begum S; Viscidi R J Natl Cancer Inst; 2008 Mar; 100(6):407-20. PubMed ID: 18334711 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]